Vicarious Surgical Inc. financial data

Symbol
RBOT, RBOT-WT on NYSE
Location
78 Fourth Avenue, Waltham, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 621 % -55%
Debt-to-equity 51.1 % +108%
Return On Equity -81.6 % -559%
Return On Assets -97.6 % -80.2%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 30.1M USD -84.4%
Common Stock, Value, Issued 11K USD +10%
Weighted Average Number of Shares Outstanding, Basic 5.94M shares +1.11%
Weighted Average Number of Shares Outstanding, Diluted 5.94M shares +1.11%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 37.7M USD -11%
Selling and Marketing Expense 3.58M USD -27.6%
General and Administrative Expense 20.7M USD -11.5%
Costs and Expenses 3.32M USD +19.6%
Operating Income (Loss) -62M USD +12.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -59.6M USD +2.29%
Net Income (Loss) Attributable to Parent -59.6M USD +2.29%
Earnings Per Share, Basic 0 USD/shares +28.5%
Earnings Per Share, Diluted 0 USD/shares +28.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.91M USD -80.7%
Cash, Cash Equivalents, and Short-term Investments 24M USD -67.3%
Assets, Current 26.1M USD -65.7%
Property, Plant and Equipment, Net 3.79M USD -28.8%
Operating Lease, Right-of-Use Asset 10.1M USD -8.58%
Other Assets, Noncurrent 21K USD -84.1%
Assets 40.9M USD -56.2%
Accounts Payable, Current 721K USD -46.8%
Employee-related Liabilities, Current 2.81M USD -15.8%
Accrued Liabilities, Current 3.07M USD -34.7%
Liabilities, Current 5.1M USD -29%
Operating Lease, Liability, Noncurrent 11.9M USD -9.92%
Liabilities 17.8M USD -17%
Accumulated Other Comprehensive Income (Loss), Net of Tax 18K USD
Retained Earnings (Accumulated Deficit) -225M USD -36.2%
Stockholders' Equity Attributable to Parent 23.1M USD -67.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 75.7M USD -41.7%
Liabilities and Equity 40.9M USD -56.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.8M USD +18.6%
Net Cash Provided by (Used in) Financing Activities 17K USD +750%
Net Cash Provided by (Used in) Investing Activities 4.61M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.85M USD -77.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1K USD -90.9%
Deferred Tax Assets, Valuation Allowance 90.4M USD +24.1%
Deferred Tax Assets, Gross 93.3M USD +22.7%
Operating Lease, Liability 13.2M USD -7.89%
Depreciation 369K USD -29.2%
Payments to Acquire Property, Plant, and Equipment 5K USD -50%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -59.6M USD +2.24%
Lessee, Operating Lease, Liability, to be Paid 17.6M USD -11.7%
Property, Plant and Equipment, Gross 10.1M USD +2.24%
Operating Lease, Liability, Current 1.31M USD +15.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.5M USD +2.96%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.43M USD +3.05%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.35M USD -21.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.57M USD +2.88%
Deferred Tax Assets, Operating Loss Carryforwards 44.4M USD +28.3%
Preferred Stock, Shares Authorized 1M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.65M USD +2.8%
Operating Lease, Payments 576K USD +3.23%
Additional Paid in Capital 248M USD +4.55%
Depreciation, Depletion and Amortization 413K USD -21.2%
Deferred Tax Assets, Net of Valuation Allowance 2.86M USD -8.69%
Share-based Payment Arrangement, Expense 11.6M USD -11.5%
Interest Expense 25K USD -87.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%